Yale-New Haven Medical Center Molecular Genetic Pathology (Multidisciplinary)

Topics

• BRCA gene mutations in cancer 45
• Gestational Trophoblastic Disease Studies 37
• Hedgehog Signaling Pathway Studies 37
• Acute Myeloid Leukemia Research 31
• HER2/EGFR in Cancer Research 27
• Endometrial and Cervical Cancer Treatments 24
• Prostate Cancer Diagnosis and Treatment 24
• SARS-CoV-2 and COVID-19 Research 23
• Ovarian cancer diagnosis and treatment 21
• Lung Cancer Treatments and Mutations 18
• SARS-CoV-2 detection and testing 17
• Iron Metabolism and Disorders 16

Most cited

1. Cell-programmed nutrient partitioning in the tumour microenvironment.

   Nature · 2021 · 890 citations · Matthew Madden

2. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 289 citations · Veda Giri

3. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2026 · 33 citations · Veda Giri

4. CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

   Nature · 2024 · 178 citations · Zenta Walther

5. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity.

   Med (New York, N.Y.) · 2021 · 230 citations · Pei Hui

6. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.

   Blood advances · 2022 · 182 citations · Alexa Siddon

7. Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline.